CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.44
+0.02 (0.24%)
At close: May 29, 2026, 4:00 PM EDT
8.40
-0.04 (-0.47%)
After-hours: May 29, 2026, 7:48 PM EDT
CorMedix Market Cap
CorMedix has a market cap or net worth of $662.13 million as of May 29, 2026. Its market cap has decreased by -15.98% in one year.
Market Cap
662.13M
Enterprise Value
631.46M
1-Year Change
-15.98%
Ranking
Category
Stock Price
$8.44
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $662.13M, an increase of 1,836.06%. That is a compound annual growth rate of 20.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 662.10M | -27.74% |
| Dec 31, 2025 | 916.30M | 86.43% |
| Dec 31, 2024 | 491.50M | 138.48% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
| May 13, 2010 | 34.20M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 703.51M |
| Tenax Therapeutics | 698.89M |
| Crescent Biopharma | 686.18M |
| Zevra Therapeutics | 685.14M |
| Design Therapeutics | 654.55M |
| SpyGlass Pharma | 643.80M |
| Prime Medicine | 641.19M |
| Aclaris Therapeutics | 635.47M |